
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
Fredrik Åberg, Jaana Helenius‐Hietala, Pauli Puukka, et al.
Hepatology (2017) Vol. 67, Iss. 6, pp. 2141-2149
Closed Access | Times Cited: 224
Fredrik Åberg, Jaana Helenius‐Hietala, Pauli Puukka, et al.
Hepatology (2017) Vol. 67, Iss. 6, pp. 2141-2149
Closed Access | Times Cited: 224
Showing 76-100 of 224 citing articles:
Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication
Mads Israelsen, Min Kim, Tommi Suvitaival, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100325-100325
Open Access | Times Cited: 38
Mads Israelsen, Min Kim, Tommi Suvitaival, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100325-100325
Open Access | Times Cited: 38
Bariatric surgery and the risk of alcohol‐related cirrhosis and alcohol misuse
Jessica L. Mellinger, Kerby Shedden, Gerald Scott Winder, et al.
Liver International (2021) Vol. 41, Iss. 5, pp. 1012-1019
Open Access | Times Cited: 37
Jessica L. Mellinger, Kerby Shedden, Gerald Scott Winder, et al.
Liver International (2021) Vol. 41, Iss. 5, pp. 1012-1019
Open Access | Times Cited: 37
Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa
C. Wendy Spearman, Mary Afihene, Omolade Adefolabi Betiku, et al.
The Lancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 12, pp. 1036-1046
Closed Access | Times Cited: 37
C. Wendy Spearman, Mary Afihene, Omolade Adefolabi Betiku, et al.
The Lancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 12, pp. 1036-1046
Closed Access | Times Cited: 37
The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification
Jürgen Rehm, Jayadeep Patra, Alan Brennan, et al.
Drug and Alcohol Review (2021) Vol. 40, Iss. 7, pp. 1377-1386
Open Access | Times Cited: 33
Jürgen Rehm, Jayadeep Patra, Alan Brennan, et al.
Drug and Alcohol Review (2021) Vol. 40, Iss. 7, pp. 1377-1386
Open Access | Times Cited: 33
Fatty Liver Disease: Diagnosis and Stratification
Yedidya Saiman, Andrés Duarte‐Rojo, Mary E. Rinella
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 529-544
Open Access | Times Cited: 33
Yedidya Saiman, Andrés Duarte‐Rojo, Mary E. Rinella
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 529-544
Open Access | Times Cited: 33
Hydroethanolic Extract of Prunus domestica L.: Metabolite Profiling and In Vitro Modulation of Molecular Mechanisms Associated to Cardiometabolic Diseases
Hammad Ullah, Eduardo Sommella, Cristina Santarcangelo, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 340-340
Open Access | Times Cited: 24
Hammad Ullah, Eduardo Sommella, Cristina Santarcangelo, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 340-340
Open Access | Times Cited: 24
The Changing Epidemiology of Alcohol-Associated Liver Disease: Gender, Race, and Risk Factors
Ahmad Anouti, Jessica L. Mellinger
Seminars in Liver Disease (2022) Vol. 43, Iss. 01, pp. 050-059
Closed Access | Times Cited: 23
Ahmad Anouti, Jessica L. Mellinger
Seminars in Liver Disease (2022) Vol. 43, Iss. 01, pp. 050-059
Closed Access | Times Cited: 23
Abdominal obesity and alcohol use modify the impact of genetic risk for incident advanced liver disease in the general population
Panu K. Luukkonen, Martti Färkkilâ, Antti Jula, et al.
Liver International (2023) Vol. 43, Iss. 5, pp. 1035-1045
Open Access | Times Cited: 14
Panu K. Luukkonen, Martti Färkkilâ, Antti Jula, et al.
Liver International (2023) Vol. 43, Iss. 5, pp. 1035-1045
Open Access | Times Cited: 14
Noninvasive assessment of hepatic decompensation
Maja Thiele, Stine Johansen, Mads Israelsen, et al.
Hepatology (2023)
Open Access | Times Cited: 14
Maja Thiele, Stine Johansen, Mads Israelsen, et al.
Hepatology (2023)
Open Access | Times Cited: 14
Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa
Mark Sonderup, Patrick S. Kamath, Yaw Asante Awuku, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 2, pp. 170-184
Closed Access | Times Cited: 5
Mark Sonderup, Patrick S. Kamath, Yaw Asante Awuku, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 2, pp. 170-184
Closed Access | Times Cited: 5
Future Trends in Demand for Liver Transplant: Birth Cohort Effects Among Patients With NASH and HCC
Alexandra Shingina, Peter DeWitt, Jennifer L. Dodge, et al.
Transplantation (2018) Vol. 103, Iss. 1, pp. 140-148
Closed Access | Times Cited: 44
Alexandra Shingina, Peter DeWitt, Jennifer L. Dodge, et al.
Transplantation (2018) Vol. 103, Iss. 1, pp. 140-148
Closed Access | Times Cited: 44
Colder Weather and Fewer Sunlight Hours Increase Alcohol Consumption and Alcoholic Cirrhosis Worldwide
Meritxell Ventura‐Cots, Ariel E. Watts, M. Cruz‐Lemini, et al.
Hepatology (2018) Vol. 69, Iss. 5, pp. 1916-1930
Open Access | Times Cited: 43
Meritxell Ventura‐Cots, Ariel E. Watts, M. Cruz‐Lemini, et al.
Hepatology (2018) Vol. 69, Iss. 5, pp. 1916-1930
Open Access | Times Cited: 43
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?
Maria Letizia Petroni, Lucia Brodosi, Francesca Marchignoli, et al.
Nutrients (2019) Vol. 11, Iss. 12, pp. 3048-3048
Open Access | Times Cited: 37
Maria Letizia Petroni, Lucia Brodosi, Francesca Marchignoli, et al.
Nutrients (2019) Vol. 11, Iss. 12, pp. 3048-3048
Open Access | Times Cited: 37
NAFLD and autoimmune hepatitis: Do not judge a book by its cover
George Ν. Dalekos, Nikolaos Gatselis, Kalliopi Zachou, et al.
European Journal of Internal Medicine (2020) Vol. 75, pp. 1-9
Closed Access | Times Cited: 34
George Ν. Dalekos, Nikolaos Gatselis, Kalliopi Zachou, et al.
European Journal of Internal Medicine (2020) Vol. 75, pp. 1-9
Closed Access | Times Cited: 34
Long‐term prognosis of patients with alcohol‐related liver disease or non‐alcoholic fatty liver disease according to metabolic syndrome or alcohol use
Marie Decraecker, Dan Dutartre, Jean‐Baptiste Hiriart, et al.
Liver International (2021) Vol. 42, Iss. 2, pp. 350-362
Closed Access | Times Cited: 31
Marie Decraecker, Dan Dutartre, Jean‐Baptiste Hiriart, et al.
Liver International (2021) Vol. 42, Iss. 2, pp. 350-362
Closed Access | Times Cited: 31
Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity
Partha Pal, Rajan Palui, Sayantan Ray
World Journal of Hepatology (2021) Vol. 13, Iss. 11, pp. 1584-1610
Open Access | Times Cited: 30
Partha Pal, Rajan Palui, Sayantan Ray
World Journal of Hepatology (2021) Vol. 13, Iss. 11, pp. 1584-1610
Open Access | Times Cited: 30
Validation of fatty liver index as a predictor of hepatic steatosis in Asian populations: Impact of alcohol consumption and sex
Takako Nomura, Masafumi Ono, Kiyoyuki Kobayashi, et al.
Hepatology Research (2023) Vol. 53, Iss. 10, pp. 968-977
Closed Access | Times Cited: 12
Takako Nomura, Masafumi Ono, Kiyoyuki Kobayashi, et al.
Hepatology Research (2023) Vol. 53, Iss. 10, pp. 968-977
Closed Access | Times Cited: 12
The independent and joint risks of alcohol consumption, smoking, and excess weight on morbidity and mortality: a systematic review and meta-analysis exploring synergistic associations
Robyn Burton, Paul Fryers, Casey Sharpe, et al.
Public Health (2023) Vol. 226, pp. 39-52
Closed Access | Times Cited: 11
Robyn Burton, Paul Fryers, Casey Sharpe, et al.
Public Health (2023) Vol. 226, pp. 39-52
Closed Access | Times Cited: 11
ALT levels, alcohol use and metabolic risk factors have prognostic relevance for liver-related outcomes in the general population
Ville Männistö, Veikko Salomaa, Antti Jula, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101172-101172
Open Access | Times Cited: 4
Ville Männistö, Veikko Salomaa, Antti Jula, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101172-101172
Open Access | Times Cited: 4
Global, regional, and national total burden related to hepatitis B in children and adolescents from 1990 to 2021
Jingbo Li, Zhiqin Gao, Heming Bai, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Jingbo Li, Zhiqin Gao, Heming Bai, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Transitioning from NAFLD to MAFLD and MASLD: the toxic relationship with alcohol consumption
Mübin Özercan, Ahmed Tawheed, Mohamed El‐Kassas
Exploration of Medicine (2025)
Open Access
Mübin Özercan, Ahmed Tawheed, Mohamed El‐Kassas
Exploration of Medicine (2025)
Open Access
Influence of Obesity Class on Clinical Outcomes in Alcoholic Hepatitis: A National Cohort Study of Mortality, Complications, and Resource Use
Ali Jaan, Mostafa Najim, Umer Farooq, et al.
JGH Open (2025) Vol. 9, Iss. 4
Open Access
Ali Jaan, Mostafa Najim, Umer Farooq, et al.
JGH Open (2025) Vol. 9, Iss. 4
Open Access
Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase
Ya‐Hui Wang, Ya‐Hui Chuang, Chih‐Feng Wu, et al.
Hepatology (2018) Vol. 69, Iss. 4, pp. 1412-1425
Closed Access | Times Cited: 37
Ya‐Hui Wang, Ya‐Hui Chuang, Chih‐Feng Wu, et al.
Hepatology (2018) Vol. 69, Iss. 4, pp. 1412-1425
Closed Access | Times Cited: 37
Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease
Fredrik Åberg, Pauli Puukka, Veikko Salomaa, et al.
Clinical Gastroenterology and Hepatology (2019) Vol. 18, Iss. 4, pp. 995-997.e2
Closed Access | Times Cited: 34
Fredrik Åberg, Pauli Puukka, Veikko Salomaa, et al.
Clinical Gastroenterology and Hepatology (2019) Vol. 18, Iss. 4, pp. 995-997.e2
Closed Access | Times Cited: 34
Serum lipopolysaccharides predict advanced liver disease in the general population
Ville Männistö, Martti Färkkilâ, Pirkko J. Pussinen, et al.
JHEP Reports (2019) Vol. 1, Iss. 5, pp. 345-352
Open Access | Times Cited: 32
Ville Männistö, Martti Färkkilâ, Pirkko J. Pussinen, et al.
JHEP Reports (2019) Vol. 1, Iss. 5, pp. 345-352
Open Access | Times Cited: 32